Cyclooxygenase- and lipoxygenase-mediated DNA damage

Cancer and Metastasis Reviews

Volumn 30, Issue 3-4, 2011, Pages 437-447

  Speed, N ^a   Blair, I A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

DNA adducts; Lipid peroxidation; Somatic mutations; Tumorigenesis

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; DNA; ELECTROPHILE; LIPID HYDROPEROXIDE; LIPOXYGENASE; PROSTAGLANDIN E2;

ARTICLE; CARCINOGENESIS; DNA DAMAGE; GENE MUTATION; HUMAN; METASTASIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; DNA ADDUCTS; DNA REPAIR; HUMANS; LIPID PEROXIDATION; LIPOXYGENASES; MUTAGENESIS; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 83855164055     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9298-8     Document Type: Article

References (112)

1. D Mangal DK Vudathala JH Park SH Lee TM Penning IA Blair 2009 Analysis of 7,8-dihydro-8-oxo-2′-deoxyguanosine in cellular DNA during oxidative stress Chemical Research in Toxicology 22 788 797 19309085 1:CAS:528: DC%2BD1MXjsFKmt7g%3D
2. JH Park D Mangal KA Tacka AM Quinn RG Harvey IA Blair, et al. 2008 Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells Proceedings of the National Academy of Sciences USA 105 6846 6851 1:CAS:528:DC%2BD1cXmt1GisLo%3D
3. FJ Gonzalez 2005 Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1 Mutation Research 569 101 110 15603755 1:CAS:528:DC%2BD2cXhtVyqsLzN
4. BN Ames MK Shigenaga TM Hagen 1993 Oxidants, antioxidants, and the degenerative diseases of aging Proceedings of the National Academy of Sciences USA 90 7915 7922 1:CAS:528:DyaK3sXmtVSksL4%3D
5. GM DeNicola FA Karreth TJ Humpton A Gopinathan C Wei K Frese, et al. 2011 Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis Nature 475 106 109 21734707 1:CAS:528:DC%2BC3MXosFemtr0%3D
6. A Churg 2003 Interactions of exogenous or evoked agents and particles: the role of reactive oxygen species Free Radical Biology & Medicine 34 1230 1235 1:CAS:528:DC%2BD3sXjt1Kgs7c%3D
7. J Cadet T Delatour T Douki D Gasparutto JP Pouget JL Ravanat, et al. 1999 Hydroxyl radicals and DNA base damage Mutation Research 424 9 21 10064846 1:CAS:528:DyaK1MXhvF2ku7s%3D
8. P Zhu T Oe IA Blair 2008 Determination of cellular redox status by stable isotope dilution liquid chromatography/mass spectrometry analysis of glutathione and glutathione disulfide Rapid Communications in Mass Spectrometry 22 432 440 18215009 1:CAS:528:DC%2BD1cXjt1aku7Y%3D
9. WP Watson A Mutti 2004 Role of biomarkers in monitoring exposures to chemicals: present position, future prospects Biomarkers 9 211 242 15764289 1:CAS:528:DC%2BD2cXhtVOms7nO
10. NA Porter SE Caldwell KA Mills 1995 Mechanisms of free radical oxidation of unsaturated lipids Lipids 30 277 290 7609594 1:CAS:528:DyaK2MXltFCqtLc%3D
11. LJ Marnett 2000 Oxyradicals and DNA damage Carcinogenesis 21 361 370 10688856 1:CAS:528:DC%2BD3cXitVeju7c%3D
12. LJ Marnett JN Riggins JD West 2003 Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein Journal of Clinical Investigation 111 583 593 12618510 1:CAS:528:DC%2BD3sXhvFentb4%3D
13. LJ Marnett 2002 Oxy radicals, lipid peroxidation and DNA damage Toxicology 181-182 219 222 12505314
14. AA Horton S Fairhurst 1987 Lipid peroxidation and mechanisms of toxicity Critical Reviews in Toxicology 18 27 79 3311640 1:CAS:528:DyaL1cXhs1Wi
15. W Völkel T Sicilia A Pahler W Gsell T Tatschner K Jellinger, et al. 2006 Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease Neurochemistry International 48 679 686 16483694
16. P Jenner 2003 Oxidative stress in Parkinson's disease Annals of Neurology 53 Suppl 3 S26 S36 12666096 1:CAS:528:DC%2BD3sXjtFGitLs%3D
17. DA Butterfield CM Lauderback 2002 Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress Free Radical Biology & Medicine 32 1050 1060 1:CAS:528:DC%2BD38XjvVehur0%3D
18. JW Heinecke 2002 Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress Free Radical Biology & Medicine 32 1090 1101 1:CAS:528:DC%2BD38XjvVehurY%3D
19. AR Brash 1999 Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate Journal of Biological Chemistry 274 23679 23682 10446122 1:CAS:528:DyaK1MXlsVOnsrc%3D
20. O Laneuville DK Breuer N Xu ZH Huang DA Gage JT Watson 1995 Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid Journal of Biological Chemistry 270 19330 19336 7642610 1:CAS:528:DyaK2MXnsFygsrw%3D
21. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics, 2010 CA: A Cancer Journal for Clinicians 60 277 300
22. A Jemal A Thomas T Murray M Thun 2002 Cancer statistics, 2002 CA: A Cancer Journal for Clinicians 52 23 47
23. A Jemal F Bray MM Center J Ferlay E Ward D Forman 2011 Global cancer statistics CA: A Cancer Journal for Clinicians 61 69 90
24. DM Parkin F Bray J Ferlay P Pisani 2001 Estimating the world cancer burden: Globocan 2000 International Journal of Cancer 94 153 156 1:CAS:528:DC%2BD3MXntVGlu78%3D
25. PA Futreal L Coin M Marshall T Down T Hubbard R Wooster, et al. 2004 A census of human cancer genes Nature Reviews Cancer 4 177 183 14993899 1:CAS:528:DC%2BD2cXhs1Ggsrg%3D
26. B Vogelstein KW Kinzler 2004 Cancer genes and the pathways they control Nature Medicine 10 789 799 15286780 1:CAS:528:DC%2BD2cXmtFWrt7o%3D
27. S Yachida S Jones I Bozic T Antal R Leary B Fu, et al. 2010 Distant metastasis occurs late during the genetic evolution of pancreatic cancer Nature 467 1114 1117 20981102 1:CAS:528:DC%2BC3cXhtlCjtrvI
28. RN Dubois SB Abramson L Crofford RA Gupta LS Simon LB van de Putte, et al. 1998 Cyclooxygenase in biology and disease The FASEB Journal 12 1063 1073 9737710 1:CAS:528:DyaK1cXlvFWntbY%3D
29. SS Pong SL Hong L Levine 1977 Prostaglandin production by methylcholanthrene-transformed mouse BALB/3T3. Requirement for protein synthesis Journal of Biological Chemistry 252 1408 1413 557039 1:CAS:528: DyaE2sXhtFyhtL8%3D
30. A Hassid L Levine 1977 Induction of fatty acid cyclooxygenase activity in canine kidney cells (MDCK) by benzo(a)pyrene Journal of Biological Chemistry 252 6591 6593 408352 1:CAS:528:DyaE2sXlsV2gsLY%3D
31. T Hla K Neilson 1992 Human cyclooxygenase-2 cDNA Proceedings of the National Academy of Sciences USA 89 7384 7388 1:CAS:528:DyaK3sXktVajurg%3D
32. R Tazawa XM Xu KK Wu LH Wang 1994 Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene Biochemical and Biophysical Research Communications 203 190 199 8074655 1:CAS:528:DyaK2cXlvFOnsro%3D
33. MT Rizzo 2011 Cyclooxygenase-2 in oncogenesis Clinica Chimica Acta 412 671 687 1:CAS:528:DC%2BC3MXit1ymtb8%3D
34. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN Dubois 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183 1188 7926468 1:STN:280: DyaK2M%2FhtFamsA%3D%3D
35. KC Zimmermann M Sarbia AA Weber F Borchard HE Gabbert K Schror 1999 Cyclooxygenase-2 expression in human esophageal carcinoma Cancer Research 59 198 204 9892207 1:CAS:528:DyaK1MXms1ejsg%3D%3D
36. AC Goulet JG Einsphar DS Alberts A Beas C Burk A Bhattacharyya, et al. 2003 Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression Cancer Biology & Therapy 2 713 718 1:CAS:528: DC%2BD2cXhvVCjsbY%3D
37. ON Tucker AJ Dannenberg EK Yang F Zhang L Teng JM Daly, et al. 1999 Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer Cancer Research 59 987 990 10070951 1:CAS:528:DyaK1MXhslemtLw%3D
38. E Richardsen RD Uglehus J Due C Busch LT Busund 2010 COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67 Cancer Epidemiology 34 316 322 20409773 1:CAS:528:DC%2BC3cXovVCksbY%3D
39. J Mrena JP Wiksten A Kokkola S Nordling A Ristimaki C Haglund 2010 COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer Tumor Biology 31 1 7 20237896 1:CAS:528:DC%2BC3cXkt1KksA%3D%3D
40. C Denkert KJ Winzer S Hauptmann 2004 Prognostic impact of cyclooxygenase-2 in breast cancer Clinical Breast Cancer 4 428 433 15023244 1:CAS:528:DC%2BD2cXjtlKisLo%3D
41. C Denkert KJ Winzer BM Muller W Weichert S Pest M Kobel, et al. 2003 Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma Cancer 97 2978 2987 12784332 1:CAS:528:DC%2BD3sXlt1Shtbo%3D
42. M Yan RM Rerko P Platzer D Dawson J Willis M Tong, et al. 2004 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers Proceedings of the National Academy of Sciences USA 101 17468 17473 1:CAS:528: DC%2BD2MXhslOjtQ%3D%3D
43. WL Chou LM Chuang CC Chou AH Wang JA Lawson GA FitzGerald, et al. 2007 Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation Journal of Biological Chemistry 282 18162 18172 17449869 1:CAS:528:DC%2BD2sXmsVOlurg%3D
44. VL Schuster 1998 Molecular mechanisms of prostaglandin transport Annual Review of Physiology 60 221 242 9558462 1:CAS:528:DyaK1cXitVOhs7Y%3D
45. T Nomura R Lu ML Pucci VL Schuster 2004 The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase Molecular Pharmacology 65 973 978 15044627 1:CAS:528:DC%2BD2cXivFaltb4%3D
46. MG Backlund JR Mann VR Holla Q Shi T Daikoku SK Dey, et al. 2008 Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer Cancer Research 68 9331 9337 19010907 1:CAS:528:DC%2BD1cXhtlOmt7vO
47. SD Markowitz MM Bertagnolli 2009 Molecular origins of cancer: molecular basis of colorectal cancer The New England Journal of Medicine 361 2449 2460 20018966 1:CAS:528:DC%2BD1MXhsFKisr7L
48. VR Holla MG Backlund P Yang RA Newman RN Dubois 2008 Regulation of prostaglandin transporters in colorectal neoplasia Cancer Prevention Research 1 93 99 19138942 1:CAS:528:DC%2BC3cXptFOisLc%3D
49. AT Chan EL Giovannucci JA Meyerhardt ES Schernhammer GC Curhan CS Fuchs 2005 Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer Journal of the American Medical Association 294 914 923 16118381 1:CAS:528:DC%2BD2MXptVClsro%3D
50. T Grosser S Fries GA FitzGerald 2006 Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities Journal of Clinical Investigation 116 4 15 16395396 1:CAS:528:DC%2BD28XjslOjtQ%3D%3D
51. C Bombardier L Laine A Reicin D Shapiro R Burgos-Vargas B Davis, et al. 2000 Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group New England Journal of Medicine 343 1520-8 2
52. MJ Langman DM Jensen DJ Watson SE Harper PL Zhao H Quan, et al. 1999 Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs Journal of the American Medical Association 282 1929 1933 10580458 1:CAS:528: DyaK1MXotVOksLo%3D
53. JA Baron RS Sandler RS Bresalier H Quan R Riddell A Lanas, et al. 2006 A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas Gastroenterology 131 1674 1682 17087947 1:CAS:528:DC%2BD2sXhtFyltL8%3D
54. SD Solomon MA Pfeffer JJ McMurray R Fowler P Finn B Levin, et al. 2006 Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas Circulation 114 1028 1035 16943394 1:CAS:528:DC%2BD28XoslOntrw%3D
55. IA Blair 2008 DNA adducts with lipid peroxidation products Journal of Biological Chemistry 283 15545 15549 18285329 1:CAS:528:DC%2BD1cXmsFekt7Y%3D
56. SH Lee K Rangiah MV Williams AY Wehr RN Dubois IA Blair 2007 Cyclooxygenase-2-mediated metabolism of arachidonic acid to 15-oxo- eicosatetraenoic acid by rat intestinal epithelial cells Chemical Research in Toxicology 20 665 1675
57. SH Lee T Oe IA Blair 2001 Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins Science 292 2083 2086 11408659 1:CAS:528:DC%2BD3MXksFOksbg%3D
58. MV Williams SH Lee IA Blair 2005 Liquid chromatography/mass spectrometry analysis of bifunctional electrophiles and DNA adducts from vitamin C mediated decomposition of 15-hydroperoxyeicosatetraenoic acid Rapid Communications in Mass Spectrometry 19 849 858 15723435 1:CAS:528:DC%2BD2MXitl2ktrs%3D
59. W Jian SH Lee C Mesaros T Oe MV Silva Elipe IA Blair 2007 A novel 4-oxo-2(E)-nonenal-derived endogenous thiadiazabicyclo glutathione adduct formed during cellular oxidative stress Chemical Research in Toxicology 20 1008 1018 17550273 1:CAS:528:DC%2BD2sXmtV2itrk%3D
60. P Zhu W Jian IA Blair 2009 A 4-oxo-2(E)-nonenal-derived glutathione adduct from 15-lipoxygenase-1-mediated oxidation of cytosolic and esterified arachidonic acid Free Radical Biology & Medicine 47 953 961 1:CAS:528:DC%2BD1MXhtVOisLjK
61. W Jian SH Lee MV Williams IA Blair 2009 5-Lipoxygenase-mediated endogenous DNA damage Journal of Biological Chemistry 284 16799 16807 19390118 1:CAS:528:DC%2BD1MXntFCjsLk%3D
62. WY Jian SH Lee IA Blair 2004 Lipoxygenase-mediated endogenous DNA damage Chemical Research in Toxicology 17 1759
63. IA Blair 2001 Lipid hydroperoxide-mediated DNA damage Experimental Gerontology 36 1473 1481 11525870 1:CAS:528:DC%2BD3MXmt1KksbY%3D
64. H Kühn M Walther RJ Kuban 2002 Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications Prostaglandins & Other Lipid Mediators 68-69 263 290
65. P Chaitidis T Schewe M Sutherland H Kühn S Nigam 1998 15-Lipoxygenation of phospholipids may precede the sn-2 cleavage by phospholipases A2: reaction specificities of secretory and cytosolic phospholipases A2 towards native and 15-lipoxygenated arachidonoyl phospholipids Federation of European Biochemical Societies Letters 434 437 441 9742970 1:CAS:528:DyaK1cXmt1yhu7o%3D
66. K Lotzer CD Funk AJ Habenicht 2005 The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis Biochimica et Biophysica Acta 1736 30 37 16081317
67. SH Lee MV Williams RN Dubois IA Blair 2003 Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry Rapid Communications in Mass Spectrometry 17 2168 2176 14515314 1:CAS:528:DC%2BD3sXotVSrsbg%3D
68. JW Woods JF Evans D Ethier S Scott PJ Vickers L Hearn, et al. 1993 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes The Journal of Experimental Medicine 178 1935 1946 8245774 1:CAS:528:DyaK3sXmt1Chsb4%3D
69. M Peters-Golden WR Henderson Jr 2005 The role of leukotrienes in allergic rhinitis Annals of Allergy, Asthma & Immunology 94 609 618 1:CAS:528:DC%2BD2MXmt1Cjtb0%3D
70. RC Murphy MA Gijon 2007 Biosynthesis and metabolism of leukotrienes Biochemical Journal 405 379 395 17623009 1:CAS:528:DC%2BD2sXns12gsr4%3D
71. O Werz 2002 5-Lipoxygenase: cellular biology and molecular pharmacology Current Drug Targets-Inflammation and Allergy 1 23 44 14561204 1:CAS:528:DC%2BD38Xptlalu7w%3D
72. JN Sharma LA Mohammed 2006 The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets? Inflammopharmacology 14 10 16 16835707 1:CAS:528:DC%2BD28XkvF2ltL0%3D
73. A Hicks SP Monkarsh AF Hoffman R Goodnow Jr 2007 Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments Expert Opinion on Investigational Drugs 16 1909 1920 18042000 1:CAS:528:DC%2BD2sXhtlGmu7%2FI
74. MP Wymann R Schneiter 2008 Lipid signalling in disease Nature Reviews Molecular Cell Biology 9 162 176 18216772 1:CAS:528:DC%2BD1cXovFOgug%3D%3D
75. M Peters-Golden 2008 Expanding roles for leukotrienes in airway inflammation Current Allergy and Asthma Reports 8 367 373 18606091 1:CAS:528:DC%2BD1cXoslOqu7Y%3D
76. L Zhao CD Funk 2004 Lipoxygenase pathways in atherogenesis Trends in Cardiovascular Medicine 14 191 195 15261891 1:CAS:528:DC%2BD2cXlslyhsbc%3D
77. D Fairweather S Frisancho-Kiss 2008 Mast cells and inflammatory heart disease: potential drug targets Cardiovascular & Hematological Disorders Drug Targets 8 80 90 1:CAS:528:DC%2BD1cXjtlGns7o%3D
78. S Gupta M Srivastava N Ahmad K Sakamoto DG Bostwick H Mukhtar 2001 Lipoxygenase-5 is overexpressed in prostate adenocarcinoma Cancer 91 737 743 11241241 1:CAS:528:DC%2BD3MXhsFCrtLo%3D
79. R Hennig XZ Ding WG Tong MB Schneider J Standop H Friess, et al. 2002 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue American Journal of Pathology 161 421 428 12163367 1:CAS:528:DC%2BD38XntFektbg%3D
80. X Chen S Sood CS Yang N Li Z Sun 2006 Five-lipoxygenase pathway of arachidonic acid metabolism in carcinogenesis and cancer chemoprevention Current Cancer Drug Targets 6 613 622 17100567 1:CAS:528:DC%2BD28XhtFSju7%2FF
81. PG Schulam WT Shearer 1990 Evidence for 5-lipoxygenase activity in human B cell lines. A possible role for arachidonic acid metabolites during B cell signal transduction Journal of Immunology 144 2696 2701 1:CAS:528: DyaK3cXkt1ajsL0%3D
82. Y el Makhour-Hojeij MC Baclet H Chable-Rabinovitch JL Beneytout J Cook 1994 Expression of 5-lipoxygenase in lymphoblastoid B and T cells Prostaglandins 48 21 29 7972877 1:CAS:528:DyaK2cXltlSksLc%3D
83. SH Lee MV Williams IA Blair 2005 Targeted chiral lipidomics analysis Prostaglandins & Other Lipid Mediators 77 141 157 1:CAS:528: DC%2BD2MXnslylu7s%3D
84. SH Lee IA Blair 2007 Targeted chiral lipidomics analysis by liquid chromatography electron capture atmospheric pressure chemical ionization mass spectrometry (LC-ECAPCI/MS) Methods in Enzymology 433 159 174 17954234 1:CAS:528:DC%2BD1cXhsVOqtr8%3D
85. W Jian SH Lee JS Arora MV Silva Elipe IA Blair 2005 Unexpected formation of etheno-2′-deoxyguanosine adducts from 5(S)-hydroperoxyeicosatetraenoic acid: evidence for a bis-hydroperoxide intermediate Chemical Research in Toxicology 18 599 610 15777099 1:CAS:528:DC%2BD2MXhsVyhsr4%3D
86. SH Lee IA Blair 2000 Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation Chemical Research in Toxicology 13 698 702 10956056 1:CAS:528:DC%2BD3cXkvVWgurY%3D
87. SH Lee T Oe IA Blair 2002 4,5-Epoxy-2(E)-decenal-induced formation of 1, N(6)-etheno-2′-deoxyadenosine and 1, N(2)-etheno-2′-deoxyguanosine adducts Chemical Research in Toxicology 15 300 304 11896675 1:CAS:528: DC%2BD38XhtFalu70%3D
88. SH Lee MVS Elipe JS Arora IA Blair 2005 Dioxododecenoic acid: a lipid hydroperoxide-derived bifunctional electrophile responsible for etheno DNA adduct formation Chemical Research in Toxicology 18 566 578 15777096 1:CAS:528:DC%2BD2MXhtl2isb8%3D
89. 2-etheno-2′-deoxyguanosine adducts Chemical Research in Toxicology 18 780 786 15833039 1:CAS:528:DC%2BD2MXislWltbc%3D
90. JA Swenberg MS Bogdanffy A Ham S Holt A Kim EJ Morinello, et al. 1999 Formation and repair of DNA adducts in vinyl chloride- and vinyl fluoride-induced carcinogenesis International Agency for Research on Cancer Scientific Publication 150 29 43 1:CAS:528:DC%2BD3cXitF2qsbg%3D
91. A Barbin H Bartsch 1986 Mutagenic and promutagenic properties of DNA adducts formed by vinyl chloride metabolites International Agency for Research on Cancer Scientific Publication 70 345 358 1:CAS:528:DyaL2sXitVyrtrw%3D
92. 2-ethenoguanine in Chinese hamster ovary cell chromosomal DNA Chemical Research in Toxicology 12 501 507 10368312 1:CAS:528:DyaK1MXjtVSmsLY%3D
93. CK Winter HJ Segall WF Haddon 1986 Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro Cancer Research 46 5682 5686 3756915 1:CAS:528:DyaL2sXhs1ar
94. G Poli F Biasi G Leonarduzzi 2008 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases Molecular Aspects of Medicine 29 67 71 18158180 1:CAS:528:DC%2BD1cXivVynuro%3D
95. JA Hankin DN Jones RC Murphy 2003 Covalent binding of leukotriene A4 to DNA and RNA Chemical Research in Toxicology 16 551 561 12703973 1:CAS:528:DC%2BD3sXitlyktr0%3D
96. D Rindgen M Nakajima S Wehrli K Xu IA Blair 1999 Covalent modifications to 2′-deoxyguanosine by 4-oxo-2-nonenal, a novel product of lipid peroxidation Chemical Research in Toxicology 12 1195 1204 10604869 1:CAS:528:DyaK1MXntV2mtrY%3D
97. SH Lee D Rindgen RH Bible Jr E Hajdu IA Blair 2000 Characterization of 2′-deoxyadenosine adducts derived from 4-oxo-2-nonenal, a novel product of lipid peroxidation Chemical Research in Toxicology 13 565 574 10898588 1:CAS:528:DC%2BD3cXjvVaiu7k%3D
98. D Rindgen SH Lee M Nakajima IA Blair 2000 Formation of a substituted 1, N(6)-etheno-2′-deoxyadenosine adduct by lipid hydroperoxide-mediated generation of 4-oxo-2-nonenal Chemical Research in Toxicology 13 846 852 10995257 1:CAS:528:DC%2BD3cXltlansLo%3D
99. M Pollack T Oe SH Lee MV Silva Elipe BH Arison IA Blair 2003 Characterization of 2′-deoxycytidine adducts derived from 4-oxo-2-nonenal, a novel lipid peroxidation product Chemical Research in Toxicology 16 893 900 12870892 1:CAS:528:DC%2BD3sXksFGhtrw%3D
100. M Pollack IY Yang HY Kim IA Blair M Moriya 2006 Translesion DNA synthesis across the heptanone-etheno-2′-deoxycytidine adduct in cells Chemical Research in Toxicology 19 1074 1079 16918247 1:CAS:528:DC%2BD28Xmsl2ktrc%3D
101. IY Yang K Hashimoto N de Wind IA Blair M Moriya 2009 Two distinct translesion synthesis pathways across a lipid peroxidation-derived DNA adduct in mammalian cells Journal of Biological Chemistry 284 191 198 18981176 1:CAS:528:DC%2BD1cXhsFCjtL%2FJ
102. H Ohmori EC Friedberg RP Fuchs MF Goodman F Hanaoka D Hinkle, et al. 2001 The Y-family of DNA polymerases Molecular Cell 8 7 8 11515498 1:CAS:528:DC%2BD3MXls1Wnurs%3D
103. RN Dubois WE Smalley 1996 Cyclooxygenase, NSAIDs, and colorectal cancer Journal of Gastroenterology 31 898 906 9027660 1:CAS:528:DyaK2sXnsFSitQ%3D%3D
104. SH Lee MV Williams RN Dubois IA Blair 2005 Cyclooxygenase-2-mediated DNA damage Journal of Biological Chemistry 280 28337 28346 15964853 1:CAS:528:DC%2BD2MXmvFSnsrs%3D
105. JR Brown RN Dubois 2005 COX-2: a molecular target for colorectal cancer prevention Journal of Clinical Oncology 23 2840 2855 15837998 1:CAS:528:DC%2BD2MXktleqt7w%3D
106. CS Williams C Luongo A Radhika T Zhang LW Lamps LB Nanney, et al. 1996 Elevated cyclooxygenase-2 levels in Min mouse adenomas Gastroenterology 111 1134 1140 8831610 1:CAS:528:DyaK28XmsFCrs74%3D
107. M Oshima JE Dinchuk SL Kargman H Oshima B Hancock E Kwong, et al. 1996 Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 803 809 8945508 1:CAS:528:DyaK28XntlymsLc%3D
108. MV Williams SH Lee M Pollack IA Blair 2006 Endogenous lipid hydroperoxide-mediated DNA-adduct formation in min mice Journal of Biological Chemistry 281 10127 10133 16449227 1:CAS:528:DC%2BD28Xjt1Kgurc%3D
109. PH Chou S Kageyama S Matsuda K Kanemoto Y Sasada M Oka, et al. 2010 Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2(E)-nonenal and 4-oxo-2(E)-hexenal in human autopsy tissues Chemical Research in Toxicology 23 1442 1448 20849149 1:CAS:528:DC%2BC3cXpt1Clt7s%3D
110. A Blackford OK Serrano CL Wolfgang G Parmigiani S Jones X Zhang, et al. 2009 SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer Clinical Cancer Research 15 4674 4679 19584151 1:CAS:528: DC%2BD1MXosV2ltLg%3D
111. A Mantovani P Allavena A Sica F Balkwill 2008 Cancer-related inflammation Nature 454 436 444 18650914 1:CAS:528:DC%2BD1cXovV2mtbg%3D
112. WR Waddell GF Ganser EJ Cerise RW Loughry 1989 Sulindac for polyposis of the colon The American Journal of Surgery 157 175 179 1:STN:280: DyaL1M%2Fos1Kiug%3D%3D